Holen Sie sich die Stockscreener-App
1.30
1.56%
0.02
Handel nachbörslich:
1.42
0.12
+9.23%
Schlusskurs vom Vortag:
$1.28
Offen:
$1.27
24-Stunden-Volumen:
105.73K
Relative Volume:
1.37
Marktkapitalisierung:
$11.16M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-2.4528
EPS:
-0.53
Netto-Cashflow:
$-22.36M
1W Leistung:
-2.21%
1M Leistung:
+2.36%
6M Leistung:
+23.81%
1J Leistung:
-47.15%
1-Tages-Spanne:
$1.2423
$1.35
1-Wochen-Bereich:
$1.2201
$1.50
52-Wochen-Spanne:
$0.95
$2.8699
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.30 | 11.16M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Can Evogene Ltd. stock withstand economic slowdownWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Why Evogene Ltd. stock is in analyst buy zoneJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Is Evogene Ltd. forming a reversal patternRisk Management & Stepwise Trade Signal Implementation - newser.com
Backtesting results for Evogene Ltd. trading strategiesWeekly Market Report & Safe Entry Point Identification - newser.com
Using data tools to time your Evogene Ltd. exitQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Evogene (NASDAQ:EVGN) - Defense World
NovoCure (NASDAQ:NVCR) vs. Evogene (NASDAQ:EVGN) Head-To-Head Analysis - Defense World
Evogene Ltd Stock Analysis and ForecastSector-Based Investing & Minimal Capital Investment - earlytimes.in
What catalysts could drive Evogene Ltd. stock higherJuly 2025 Setups & Consistent Growth Equity Picks - newser.com
Why retail investors favor Evogene Ltd. stockGDP Growth & Weekly High Return Forecasts - newser.com
Is Evogene Ltd. stock a safe buy before earningsPortfolio Growth Summary & Technical Entry and Exit Alerts - newser.com
Statistical indicators supporting Evogene Ltd.’s strengthFed Meeting & Daily Chart Pattern Signal Reports - newser.com
Evogene Ltd. Releases Financial Results for First Half of 2025 - MSN
Can Evogene Ltd. recover in the next quarter2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
How to read the order book for Evogene Ltd.2025 Institutional Moves & Real-Time Volume Analysis - newser.com
What analysts say about Evogene Ltd stockAnalyst Downgrades & Low Risk Capital Growth Plans - earlytimes.in
What drives Evogene Ltd stock priceRetail Investor Activity & Small Capital Investment Tips - earlytimes.in
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):